We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 690 results
  1. Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study

    Purpose

    Evaluate the percentage of patients with prostate cancer treated with luteinizing hormone-releasing hormone analogues (LHRHa) that develop...

    J. C. Angulo, J. P. Ciria Santos, ... Almudena Zapatero in World Journal of Urology
    Article Open access 04 September 2022
  2. Subcapsular orchiectomy versus total orchiectomy and LHRH analogue in the treatment of hormone-sensitive metastatic prostate cancer: a different perspective in evaluation of the psychosocial effects

    Purpose

    We aimed to compare total orchiectomy, subcapsular orchiectomy, and luteinizing hormone-releasing hormone (LHRH) analogue treatment in...

    Ismail Selvi, Halil Basar in Supportive Care in Cancer
    Article 07 January 2020
  3. Incidence of hypertension in young transgender people after a 5-year follow-up: association with gender-affirming hormonal therapy

    In order to assess the risk of hypertension development, we performed a retrospective analysis of the clinical records of consecutive transgender...

    Francisco Javier Martinez-Martin, Agnieszka Kuzior, ... Maria del Pino Perez-Garcia in Hypertension Research
    Article 14 October 2022
  4. Central precocious puberty secondary to postoperative craniopharyngioma: two case reports and a literature review

    Background

    Craniopharyngioma is a common intracranial tumour in children. Clinical manifestations are related to hypothalamic/pituitary deficiencies,...

    Ruyuan Zhu, Luyao Wang, ... **ao**g Liu in Child's Nervous System
    Article 18 April 2024
  5. Systematic risk analysis of radiation pneumonitis in breast cancer: role of cotreatment with chemo-, endocrine, and targeted therapy

    Purpose

    A major complication of sequential and concomitant chemoradiation in breast cancer treatment is interstitial pneumonitis induced by radiation...

    Julian Mangesius, Danijela Minasch, ... Thomas Seppi in Strahlentherapie und Onkologie
    Article Open access 14 December 2022
  6. Development of a Novel Patient-Reported Outcome Measure to Assess Symptoms and Impacts of Androgen Deprivation Therapy for Advanced Prostate Cancer

    Introduction

    This qualitative research study was conducted to develop a novel, comprehensive, patient-reported outcome measure (PRO), the “Symptoms...

    Ashley Ross, Kelsie Brewer, ... Elke Hunsche in Advances in Therapy
    Article Open access 11 June 2024
  7. Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry

    Purpose

    The monarchE trial showed that the addition of abemaciclib improves efficacy in patients with high-risk early breast cancer (EBC). We analyzed...

    Miguel Martín, Eva Carrasco, ... David Aguiar-Bujanda in Breast Cancer Research and Treatment
    Article Open access 20 June 2023
  8. Antineoplastics

    Article 29 April 2023
  9. PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative “triplet” for oligometastatic hormone sensitive prostate cancer patients

    Earlier treatment intensification with systemic potent androgen receptor inhibition has been shown to improve clinical outcomes in metastatic hormone...

    Giulio Francolini, Angelo Porreca, ... Lorenzo Livi in Medical Oncology
    Article 29 December 2023
  10. Impact of Systemic Therapy on Fertility in Women with Early-Stage Breast Cancer

    Purpose of Review

    Fertility concerns are common among young women diagnosed with breast cancer, as systemic therapy increases the risk of premature...

    Kelsey H. Natsuhara, A. Jo Chien in Current Breast Cancer Reports
    Article Open access 03 January 2024
  11. Bone loss induced by cancer treatments in breast and prostate cancer patients

    Cancer and cancer therapies are a major factor risk for osteoporosis due to bone loss and deterioration of bone microarchitecture. Both factors...

    Santos Castañeda, Ana Casas, ... Álvaro Rodríguez-Lescure in Clinical and Translational Oncology
    Article Open access 02 July 2022
  12. The effect of unusual presentation on delayed diagnosis of prostate cancer: a case series

    Background

    Early diagnosis of prostate cancer is key to achieving a cure and its proper management leads to a good prognosis. In Ghana a large...

    Mawuenyo Attawa Oyortey, Kekeli Kodjo Adanu, Mahamudu Ayamba Ali in Journal of Medical Case Reports
    Article Open access 22 May 2024
  13. A multicentre randomised controlled trial of a guided self-help cognitive behavioural therapy to MANage the impact of hot flushes and night sweats in patients with prostate CANcer undergoing androgen deprivation therapy (MANCAN2)

    Background

    Androgen deprivation therapy (ADT) is prescribed to almost half of all men diagnosed with prostate cancer. Although ADT is effective...

    Simon Crabb, Alannah Morgan, ... Jonathan Martin in Trials
    Article Open access 10 July 2023
  14. Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer

    Purpose

    A major question when treating HR+/HER2− metastatic breast cancer (MBC) is whether early introduction of chemotherapy (CT) increases endocrine...

    Pauline Corbaux, Audrey Lardy-Cleaud, ... Thomas Bachelot in Breast Cancer Research and Treatment
    Article 23 October 2021
  15. Triple-arm androgen blockade for advanced prostate cancer: a review

    Prostate cancer is estimated to be the second most common malignancy in men in the USA in 2020 and represents the second highest mortality from...

    Milap H. Desai, Meghana Parsi, Rashmika R. Potdar in Medical Oncology
    Article 25 May 2021
  16. The effects of the covid-19 pandemic on puberty: a cross-sectional, multicenter study from Turkey

    Backgrounds

    During the Coronavirus-19 disease (Covid-19) pandemic it was observed that the number of girls presenting with early puberty had...

    Gul Yesiltepe Mutlu, Elif Eviz, ... Sukru Hatun in Italian Journal of Pediatrics
    Article Open access 13 August 2022
  17. SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)

    Breast cancer is the leading cause of cancer in women in Spain and its annual incidence is rapidly increasing. Thanks to the screening programs in...

    Francisco Ayala de la Peña, Silvia Antolín Novoa, ... Eva Ciruelos in Clinical and Translational Oncology
    Article Open access 16 June 2023
  18. Central precocious puberty secondary to peripheral precocious puberty due to a pineal germ cell tumor: a case and review of literature

    Background

    The pineal lesion affecting melatonin is a rare cause of central precocious puberty by decreasing the inhibition of...

    Han Chen, Cai-Yan Mo, Li-yong Zhong in BMC Endocrine Disorders
    Article Open access 26 October 2023
  19. Postmyomectomy uterocutaneous fistula: a case report and literature review

    Background

    Uterocutaneous fistula (UCF) is an uncommon clinical entity. The aetiology and optimal treatment strategy of UCF are still not clear. GnRHa...

    Caixia Han, Wenxiu Zhang, ... Lei Cheng in Archives of Gynecology and Obstetrics
    Article 21 January 2022
Did you find what you were looking for? Share feedback.